This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Gábor Gigler: Innovator in Pharmaceutical Chemistry
Introduction
Gábor Gigler is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain.
Latest Patents
Gábor Gigler holds a patent for "8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors." This patent describes a novel compound that possesses unique competitive AMPA/kainate antagonist properties. The compound, along with its pharmaceutically acceptable quaternary ammonium salts, is useful in treating diseases where inhibition of the AMPA/kainate receptors may have a favorable effect. The complete description of the compound is detailed in the patent specification.
Career Highlights
Gábor Gigler is associated with Egis Gyogyszergyar Rt., a prominent pharmaceutical company in Hungary. His work focuses on innovative solutions that enhance therapeutic options for various medical conditions.
Collaborations
Gábor has collaborated with notable colleagues, including Zoltán Rátkai and Károly Tihanyi. Their combined expertise contributes to the advancement of pharmaceutical research and development.
Conclusion
Gábor Gigler's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the field. His work continues to impact the development of new treatments for neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile